Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older at the time of joining the trial
- Men who have been diagnosed with prostate cancer (confirmed by a tissue sample) and are currently receiving or are planned to receive a hormone therapy called ADT (androgen deprivation therapy) using a type of medication known as LHRHa
- Men who have been on ADT for no more than eight weeks at the time of joining the trial
- People who are planned to receive radiotherapy as part of their treatment
- People whose clinical team has assessed them as safe to exercise and safe to participate in the trial, with no absolute barriers to exercise
- People who are able to use the technology involved in the trial, including a platform called MyMarsden and a device that supports video calls
- People who are fluent in English and able to follow instructions
- People who have a general activity level rated between 0 and 2 on the WHO performance scale — meaning they are able to carry out at least some daily activities (confirm with trial site)
- People who are able to give written consent to participate
Who may not be able to join:
- Men who are planned to receive a specific type of hormone-targeting medication (called an androgen receptor-targeted agent or ARTA) or chemotherapy
- People with certain heart or health conditions that make exercise unsafe, including: new chest pain (angina), new or unstable heart failure, newly diagnosed and uncontrolled diabetes, new or unstable irregular heartbeat, a resting heart rate that is too fast or too slow (not related to medication changes), low blood pressure causing symptoms, or high blood pressure that is not controlled
- People who have unstable cancer spread to the bones of the spine, or who are at high risk of a bone fracture
- People who have a muscle or joint problem that prevents them from exercising
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The primary endpoint is adherence to physical activity and exercise guidelines assessed using device-based activity data and self-reported physical activity and exercise data at six-months post-radiotherapy.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.